AXCELLA HEALTH INC (AXLA)

US05454B2043 - Common Stock

4.58  -0.9 (-16.42%)

After market: 3.42 -1.16 (-25.33%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
14.05M23.39MN/AN/AN/A
Gross Profit
-14.05M-23.39MN/AN/AN/A
Operating Expenses
27.52M49.41M61.85M53.84M57.44M
Research and Development
21.60M42.41M43.14M37.04M41.66M
Selling, General, and Administrative Expenses
5.94M6.99M18.71M16.80M15.78M
Operating Income
-41.57M-72.80M-61.85M-53.84M-57.44M
Interest Income/Expense
-880.00K-2.52M-2.78M-2.70M-1.58M
Other Income/Expense
20.00K-80.00K0.0010.00K-20.00K
Non Recurring Items
N/A-5.79MN/AN/AN/A
Income Before Taxes
-48.23M-81.19M-64.63M-56.53M-59.04M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-48.23M-81.19M-64.63M-56.53M-59.08M
EBITDA
-41.30M-72.39M-61.56M-53.42M-56.78M
 
Per Share Data
EPS Diluted Total Ops
-19.12-37.41-42.51-44.51-88.17
Non GAAP EPS
-19.25-38.25-12.73-1.87-4.81
 
Statistics

All data in USD

Charts